Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for PBC patients: drug aims to slow liver damage

NCT ID NCT06016842

Disease control Sponsor: Ipsen Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 01, 2026 · Updated 6 times

Summary

This Phase 3 trial tests elafibranor, a daily pill, against a placebo in 276 adults with primary biliary cholangitis (PBC) and cirrhosis. The goal is to see if elafibranor can prevent disease worsening, such as liver failure or death, over up to 3.5 years. Researchers will also monitor side effects and symptoms like itching and fatigue.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
elafibranor
What this could lead to
If it works, this could provide a new treatment option to slow liver damage and delay the need for a liver transplant in people with primary biliary cholangitis.
What could go wrong
This is a Phase 3 trial, but it's still testing if elafibranor works better than a placebo. Results may not show a clear benefit, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 276 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2023

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Male or female participants must be ≥18 years of age at the time of signing the informed consent. * Participants with a definite or probable diagnosis of primary biliary cholangitis (PBC) * Participants with cirrhosis at SV1. • Participants must be Child Pugh A or Child Pugh B. * Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies. * Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol. Exclusion Criteria : * History or presence of other concomitant liver disease including but not limited to: * i) Primary sclerosing cholangitis (PSC). * ii) Autoimmune hepatitis (AIH) by simplified Diagnostic Criteria of the International Autoimmune Hepatitis Group (IAIHG) ≥6, or if treated for an overlap of PBC with AIH, or if there is clinical suspicion and evidence of overlap AIH features, that cannot be explained alone by insufficient response to UDCA. * iii) Positive hepatitis B surface antigen (HBsAg). Participants with negative HBsAg and positive hepatitis B core antibody (HBcAb) may be eligible if hepatitis B virus deoxyribonucleic acid (HBV DNA) is negative. * iv) Hepatitis C virus (HCV) infection defined by positive anti-HCV antibody and positive HCV ribonucleic acid (RNA) (Note: Participants with positive anti-HCV antibody due to previously treated HCV infection, may be enrolled if a confirmatory HCV RNA is undetectable and sustained viral response has been documented). * v) Alcohol-associated liver disease (ALD). * vi) Nonalcoholic steatohepatitis (NASH). * vii) Other chronic liver diseases, such as alpha-1 antitrypsin deficiency. * History or presence of clinically significant hepatic decompensation, including: * i) History of liver transplantation, current placement on a liver transplant list, current model for end-stage liver disease including (MELD) 3.0 score \>12 due to hepatic impairment. * ii) Evidence of complications of cirrhosis, including hepatic decompensation or evidence of significant portal hypertension complications including presence of uncontrolled ascites; history of variceal bleeding or related interventions (e.g. variceal banding, or transjugular intrahepatic portosystemic shunt placement); presence of hepatic encephalopathy Grade 2 or higher per West-Haven criteria; history or presence of spontaneous bacterial peritonitis. Note: participants with low-risk varices (Grade I) without history of bleeding or other treatment may be eligible to enrol. * iii) Hepatorenal syndrome (HRS) (type I or II ). • vi) Hospitalisation for liver-related complication within 12 weeks prior to SV1. * Known history of human immunodeficiency virus (HIV) infection or having a positive confirmatory test for HIV type 1 or 2. * Medical conditions that may cause non-hepatic increases in ALP (e.g. Paget's disease). * Evidence of any other unstable or untreated clinically significant immunological, endocrine, hematologic, gastrointestinal, neurological, or psychiatric disease as evaluated by the investigator; other clinically significant conditions that are not well controlled. * Non-hepatic medical conditions that may diminish life expectancy to \<2 years, including known cancers. * History of hepatocellular carcinoma. * Alpha-fetoprotein (AFP) \>20 ng/mL with 4-phase liver computerised tomography (CT) or magnetic resonance imaging (MRI) imaging suggesting presence of hepatocellular carcinoma. * Known malignancy or history of malignancy within the last 5 years. Participants with non-melanoma skin cancer, or carcinoma in situ (e.g. breast carcinoma, cervical cancer in situ) that have undergone potentially curative therapy are not excluded. * Administration of the following medications is prohibited during the study, and prior to the study as per the timelines specified below: • i) 3 months prior to baseline: fibrates, seladelpar, glitazones, obeticholic acid, azathioprine, cyclosporine, methotrexate, mycophenolate, pentoxifylline, budesonide and other systemic corticosteroids (parenteral and oral chronic administration only); potentially hepatotoxic drugs (including α-methyl-dopa, sodium valproic acid, isoniazid or nitrofurantoin). * Participants who are currently participating in, plan to participate in, or have participated in an investigational drug study or medical device study containing active substance within 30 days or 5 half-lives, whichever is longer, prior to the screening period. i) If the previous study was for an experimental therapy being studied for potential benefit in PBC, and the potential therapeutic agent was proven to have no beneficial effect in PBC and there are no safety concerns, the participant may enrol after 30 days or 5 half-lives from the last dose of the therapeutic agent, whichever is longer.ii) For therapeutic agents being studied for potential benefit in PBC for which it is still unclear if there may be a potential benefit, participants may enrol after 6 months from the last dose of the therapeutic agent. * Electrocardiogram (ECG) with QT interval corrected by Fridericia's formula (QTcF) \>450 msec in males or QTcF \>470 msec in females for participants without bundle branch block. For participants with bundle branch block or other intraventricular conduction delay, a longer QTcF \>480 msec would be exclusionary. * Total bilirubin (TB) \>5x ULN * Alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) \>5x ULN at SV1 * Creatinine phosphokinase (CPK) \>2x ULN. * Platelet count \<50,000/μL * International normalised ratio (INR) \>1.8 in the absence of anticoagulant therapy. * Estimated glomerular filtration rate (eGFR) \<45 mL/min/1.73m2 per the Modification of Diet in Renal Disease (MDRD)-6 Study formula at SV1. * Significant renal disease, including nephritic syndrome, chronic kidney disease (CKD) (defined as participants with evidence of significantly impaired kidney function or underlying kidney injury). * For female participants: known current pregnancy, or has a positive serum pregnancy test, or is breastfeeding. * Participants unwilling or unable to be abstinent from alcohol during the study. * History of alcohol abuse, or other substance abuse within 1 year prior to SV1. * Known hypersensitivity to elafibranor or to any of the excipients of the investigational product(s). * Mental instability or incompetence, such that the validity of informed consent or ability to be compliant with the study is uncertain. * Any other condition that, in the opinion of the investigator, would interfere with study participation or completion, or would put the participant at risk, including a potential participant assessed as being at high risk of noncompliance with the study. * Alkaline phosphatase (ALP) ≥10x ULN. * Albumin \<2.8 g/dL due to impaired hepatic function.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary biliary cholangitis (PBC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

primary biliary cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Primary biliary cholangitis (PBC)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    132 sites in 24 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Agios Savvas Regional Cancer Hospital

    RECRUITING

    Athens, Greece

  • Algemeen Ziekenhuis Delta

    WITHDRAWN

    Roeselare, Belgium

  • American Research Corporation

    RECRUITING

    Austin, Texas, 78757, United States

  • American Research Corporation at The Texas Liver Institute

    RECRUITING

    San Antonio, Texas, 78015, United States

  • Arizona Liver Health

    RECRUITING

    Tucson, Arizona, 85641, United States

  • Arkansas Diagnostic Center, PA

    TERMINATED

    Little Rock, Arkansas, 55130, United States

  • Artroscan

    RECRUITING

    Ostrava, Czechia

  • Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

    TERMINATED

    Palermo, Italy

  • Azienda Ospedaliera di Padova - U.O.C. di Gastroenterologia

    WITHDRAWN

    Padova, Italy

  • Azienda Ospedaliero Universitaria Federico II di Napoli

    TERMINATED

    Naples, Italy

  • Azienda Ospedaliero Universitaria Modena

    WITHDRAWN

    Modena, Italy

  • Azienda Ospedaliero Universitaria Pisana

    WITHDRAWN

    Pisa, Italy

  • Baylor Scott & White All Saints Medical Center - Forth Worth

    WITHDRAWN

    Fort Worth, Texas, 76104, United States

  • Bispebjerg Hospital

    RECRUITING

    Copenhagen, Denmark

  • Bolanos Clinical Research

    RECRUITING

    Pembroke Pines, Florida, 12105, United States

  • Bon Secours St. Mary's Hospital of Richmond, Inc

    RECRUITING

    Richmond, Virginia, 23226, United States

  • CHA Bundang Medical Center, CHA University

    RECRUITING

    Seongnam-si, South Korea

  • CHU Poitiers

    WITHDRAWN

    Poitiers, France

  • CHU de Nice, Hopital de l'Archet

    RECRUITING

    Nice, France

  • Canterbury District Health Board

    RECRUITING

    Christchurch, New Zealand

  • Cedars-Sinai Medical Center

    WITHDRAWN

    Los Angeles, California, 90048, United States

  • Central Hospital of Northern Pest - Military Hospital

    RECRUITING

    Budapest, Hungary

  • Centre Hospitalier Regional Universitaire de Lille - Hopital Claude Huriez

    WITHDRAWN

    Lille, France

  • Centro Medico Cedid - Centro de Diagnostico Digestivo

    RECRUITING

    Viña del Mar, Chile

  • Centro Medico Colon

    RECRUITING

    Córdoba, Argentina

  • Centro de Estudios Clinicos e Investigaciones Medicas (CECIM)

    RECRUITING

    Santiago, Chile

  • Centro de Investigacion Clinica y Medicina Traslacional

    RECRUITING

    Guadalajara, Mexico

  • Centro de Investigacion Medico Biologica y Terapia Avanzada

    RECRUITING

    Jalisco, Mexico

  • Centro de Investigacion y Gastroenterologia SC

    RECRUITING

    Mexico City, Mexico

  • Centrul Pentru Studiul Metabolismului

    RECRUITING

    Bucharest, Romania

  • Centrum Medyczne Medyk Sp. z o.o. Sp. K.

    RECRUITING

    Rzeszów, Poland

  • Chiang Mai University

    RECRUITING

    Chiang Mai, Thailand

  • Chung-Ang University Hospital

    WITHDRAWN

    Seoul, South Korea

  • Clinica Universidad Navarra-Sede Madrid

    RECRUITING

    Madrid, Spain

  • Clinique Pasteur

    WITHDRAWN

    Toulouse, France

  • Cluj County Clinical Emergency Hospital

    RECRUITING

    Cluj-Napoca, Romania

  • DIM Centro Medico

    RECRUITING

    Buenos Aires, Argentina

  • Diagnostic-Consultative Center Aleksandrovska EOOD

    ACTIVE_NOT_RECRUITING

    Sofia, Bulgaria

  • Enroll SpA

    RECRUITING

    Santiago, Chile

  • Fakultna nemocnica Nitra

    RECRUITING

    Nitra, Slovakia

  • Fondazione I.R.C.C.S. Policlinico San Matteo

    WITHDRAWN

    Pavia, Italy

  • Footscray Hospital, Western Health

    RECRUITING

    Footscray, Australia

  • Fundacion Respirar (Centro Medico Dra. De Salvo) - Instituto Argentino de Investigaciones Clinicas (IAIC) S.R.L

    RECRUITING

    Buenos Aires, Argentina

  • FutureMeds Warszawa Centrum

    RECRUITING

    Warsaw, Poland

  • FutureMeds sp. z o. o

    RECRUITING

    Wroclaw, Poland

  • Galilee Medical Center

    TERMINATED

    Nahariya, Israel

  • Galilee Medical Center, ZIV Medical Center

    WITHDRAWN

    Nahariya, Israel

  • Gastro health & Nutrition

    TERMINATED

    Katy, Texas, 77904, United States

  • GastroIntestinal BioSciences

    ACTIVE_NOT_RECRUITING

    Los Angeles, California, 90067, United States

  • Gastroenterological Centre Thalion

    RECRUITING

    Bratislava, Slovakia

  • Gastroenterology Center of the Midsouth

    RECRUITING

    Cordova, Tennessee, 38138, United States

  • Gastromedica Srl

    RECRUITING

    Iași, 700111, Romania

  • GeneIppokratio General Hospital of Thessaloniki

    RECRUITING

    Thessaloniki, Greece

  • General Hospital of Athens Laiko

    RECRUITING

    Athens, Greece

  • General Oncological Hospital of Kifisia Oi Agioi Anargyroi

    RECRUITING

    Athens, Greece

  • Gent University Hospital

    RECRUITING

    Ghent, Belgium

  • Hadassah University Hospital (HUH) - Ein-Kerem

    TERMINATED

    Jerusalem, Israel

  • Hallym University Kangnam Sacred Heart Hospital

    WITHDRAWN

    Seoul, South Korea

  • Hanyang University Seoul Hospital

    RECRUITING

    Seoul, South Korea

  • Hepato-Gastroenterologie HK, s.r.o.

    RECRUITING

    Hradec Králové, Czechia

  • Hopital Paul-Brousse - APHP

    WITHDRAWN

    Villejuif, France

  • Hopital Pitie-Salpetriere - APHP

    RECRUITING

    Paris, 75013, France

  • Hopital Saint Joseph - Marseille

    WITHDRAWN

    Marseille, France

  • Hospices Civils de Lyon (HCL) - Hopital de la Croix-Rousse

    RECRUITING

    Lyon, France

  • Hospitais da Universidade de Coimbra (H.U.C) - Universidade de Coimbra

    RECRUITING

    Coimbra, Praceta Mota Pinto, Portugal

  • Hospital Angeles Valle Oriente

    RECRUITING

    Monterrey, Mexico

  • Hospital Britanico de Buenos Aires

    RECRUITING

    Buenos Aires, Argentina

  • Hospital Clinic i Provincial de Barcelona

    RECRUITING

    Barcelona, Spain

  • Hospital Clinico de la Pontificia Universidad Catolica de Chile

    RECRUITING

    Santiago, Chile

  • Hospital De Montecelo

    RECRUITING

    Pontevedra, Spain

  • Hospital Dr. Nelio Mendonca

    RECRUITING

    Funchal, 9004-514, Portugal

  • Hospital El Cruce

    RECRUITING

    San Juan Bautista, Argentina

  • Hospital Espanol de Mendoza

    WITHDRAWN

    Mendoza, Argentina

  • Hospital General Universitario Gregorio Maranon (HGUGM)

    ACTIVE_NOT_RECRUITING

    Madrid, Spain

  • Hospital Henri Mondor

    RECRUITING

    Créteil, 94000, France

  • Hospital Italiano de Buenos Aires

    RECRUITING

    Buenos Aires, Argentina

  • Hospital Queen Elizabeth II

    RECRUITING

    Kota Kinabalu, Malaysia

  • Hospital Sultanah Aminah

    RECRUITING

    Johor Bahru, Malaysia

  • Hospital Universitario Austral

    RECRUITING

    Pilar, Argentina

  • Hospital Universitario La Paz

    WITHDRAWN

    Madrid, Spain

  • Hospital Universitario Miguel Servet

    RECRUITING

    Zaragoza, Spain

  • Hospital Universitario Puerta de Hierro de Majadahonda

    RECRUITING

    Majadahonda, Spain

  • Hospital Universitario Rio Hortega

    WITHDRAWN

    Valladolid, Spain

  • Hospital Universitario Vall d'Hebron

    RECRUITING

    Barcelona, Spain

  • Hospital Universitario Virgen de la Victoria

    RECRUITING

    Málaga, Spain

  • Hospital Universitario Virgen del Rocio

    RECRUITING

    Seville, Spain

  • Hospital Universitario y Politecnico La Fe

    TERMINATED

    Valencia, 46026, Spain

  • Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo

    RECRUITING

    São Paulo, Brazil

  • Hospital de Base - Centro Integrado de Pesquisa ( CIP )

    RECRUITING

    São Paulo, Brazil

  • Hospital de Clinicas de Porto Alegre (HCPA)

    RECRUITING

    Porto Alegre, Brazil

  • Hospital of Lithuanian University of Health Sciences Kaunas

    RECRUITING

    Kaunas, Lithuania

  • Houston Methodist Cancer Center

    ACTIVE_NOT_RECRUITING

    Houston, Texas, 77584, United States

  • Huron Gastroenterology Associates - Center for Digestive Care

    WITHDRAWN

    Ypsilanti, Michigan, 48197, United States

  • Impact Research Tx

    WITHDRAWN

    Waco, Texas, 76710, United States

  • Inha University Hospital

    RECRUITING

    Incheon, South Korea

  • Inje University Ilsan Paik Hospital

    RECRUITING

    Goyang-si, South Korea

  • Institut d Investigacio i Innovacio Parc Tauli, Hospital Universitari Parc Tauli

    ACTIVE_NOT_RECRUITING

    Sabadell, Spain

  • Institute for Clinical and Experimental Medicine - IKEM

    RECRUITING

    Prague, Czechia

  • Institute of Gastroenterology and Liver Diseases - Soroka University Medical Center

    WITHDRAWN

    Beersheba, Israel

  • Instituto D'Or de Pesquisa e Ensino - Hospital Aliança

    RECRUITING

    Salvador, Brazil

  • International Center for Research

    RECRUITING

    Tampa, Florida, 33614, United States

  • Keimyung University Dongsan Hospital

    RECRUITING

    Daegu, South Korea

  • Kenezy County Hospital

    RECRUITING

    Debrecen, Hungary

  • Korea University Ansan Hospital

    WITHDRAWN

    Gyeonggi-do, South Korea

  • Korea University Guro Hospital

    RECRUITING

    Seoul, South Korea

  • Krajska Nemocnice Liberec

    WITHDRAWN

    Liberec, Czechia

  • Krakowskie Centrum Medyczne Sp.z.o.o - FutureMeds

    RECRUITING

    Krakow, Poland

  • Krakowskie Centrum Medyczne Sp.z.o.o. - FutureMeds

    NOT_YET_RECRUITING

    Małogoskie, Poland

  • Kyungpook National University Hospital (KNUH)

    RECRUITING

    Junggu, South Korea

  • Liver Associates of Texas

    RECRUITING

    Houston, Texas, 77030, United States

  • Liver Center of Texas

    TERMINATED

    Dallas, Texas, 75203, United States

  • Louisiana Research Center, LLC

    RECRUITING

    Shreveport, Louisiana, 71103, United States

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

  • Medical Care & Research

    RECRUITING

    Yucatán, Mexico

  • Medical University of South Carolina

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Medrise Sp. z o.o.

    RECRUITING

    Lublin, Poland

  • Medstar Georgetown Transplant Institute University Hospital (MGUH)

    WITHDRAWN

    Columbia, Washington, 20007, United States

  • Methodist Transplant Physicians

    RECRUITING

    Dallas, Texas, 75203, United States

  • Monash University - Monash Health -Monash Medical Centre

    WITHDRAWN

    Melbourne, Australia

  • NUPEC Cardio

    RECRUITING

    Belo Horizonte, Brazil

  • NYU Langone Gastroenterology and Hepatology Associates

    RECRUITING

    New York, New York, 10016, United States

  • NZOZ Twoje Zdrowie EL Sp. z o.o.

    RECRUITING

    Elblag, Poland

  • Nepean Clinical School

    WITHDRAWN

    Kingswood, Australia

  • Niepubliczny Zaklad Opieki Zdrowotnej (NZOZ) - Poliklinika Doktora Bessera

    WITHDRAWN

    Sosnowiec, Poland

  • Nzoz Centrum BadanKlinicznych

    RECRUITING

    Wroclaw, Poland

  • Oddzial Kliniczny Gastroenterologii Ogolnej i Onkologicznej SPZOZ, Uniwersytecki Szpital Kliniczny im. Barlickiego w Lodzi

    RECRUITING

    Lodz, 90-153, Poland

  • Ospedale Casa Sollievo della Sofferenza

    WITHDRAWN

    San Giovanni Rotondo, Italy

  • Ospedale San Gerardo

    ACTIVE_NOT_RECRUITING

    Monza, Italy

  • Peak Gastroenterology Associates

    RECRUITING

    Colorado Springs, Colorado, 80829, United States

  • PlanetMed Sp. z o.o.

    RECRUITING

    Wroclaw, Poland

  • Prince of Songkla University (PSU) - Songklanagarind Hospital

    RECRUITING

    Hat Yai, Thailand

  • Pusan National University Hospital (PNUH)

    RECRUITING

    Busan, South Korea

  • Rabin Medical Center - Beilinson Hospital - Liver Institute

    WITHDRAWN

    Petah Tikva, Israel

  • Rambam Health Care Campus (RHCC)

    WITHDRAWN

    Haifa, Israel

  • Research Site s.r.o.

    RECRUITING

    Pilsen, Czechia

  • Rocky Mountain Gastroenterology

    RECRUITING

    Littleton, Colorado, 80120, United States

  • Rush University Medical Center - University Cardiovascular Surgeons

    WITHDRAWN

    Dallas, Texas, 60612, United States

  • Samsung Medical Center

    RECRUITING

    Seoul, South Korea

  • Sana S.R.L

    RECRUITING

    Bucharest, Romania

  • Seoul National University Bundang Hospital (SNUBH)

    RECRUITING

    Seoul, South Korea

  • Seoul National University Hospital

    RECRUITING

    Seoul, South Korea

  • Severance Hospital, Yonsei University Health System

    TERMINATED

    Seoul, South Korea

  • Shaare Zedek Medical Center

    TERMINATED

    Jerusalem, Israel

  • South Denver Gastroenterology, P.C.

    RECRUITING

    Englewood, Colorado, 80113, United States

  • Southern California Research Center

    RECRUITING

    Coronado, California, 92118, United States

  • Southwest Gastroenterology Associates, PC (SWGA)

    TERMINATED

    Albuquerque, New Mexico, 87109, United States

  • Spital Clinic Dr I Cantacuzino

    RECRUITING

    Bucharest, Romania

  • Srinagarind Hospital - Khon Kaen University

    RECRUITING

    Khon Kaen, Thailand

  • St George Hospital

    WITHDRAWN

    Sydney, Australia

  • Sunshine Coast University Hospital

    RECRUITING

    Birtinya, Australia

  • Szegedi Tudomanyegyetem AOK, I. sz Belgyogyaszati Klinika

    RECRUITING

    Szeged, Hungary

  • Szpital Uniwersytecki w Krakowie

    WITHDRAWN

    Krakow, Poland

  • Texas Clinical Research Institute

    RECRUITING

    Arlington, Texas, 22201, United States

  • The Catholic University of Korea Daejeon St.Mary's Hospital

    WITHDRAWN

    Daejeon, South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    RECRUITING

    Seoul, South Korea

  • The Catholic University of Korea, Seoul St. Mary's Hospital

    RECRUITING

    Seoul, South Korea

  • The Catholic University of Korea, Uijeongbu St. Mary's Hospital

    RECRUITING

    Uijeongbu-si, South Korea

  • Tokuda Hospital, Dept. of Internal Medicine

    RECRUITING

    Sofia, Bulgaria

  • Unidade Local de Saúde de Trás-os-Montes e Alto Douro, E. P. E

    RECRUITING

    Vila Real, 5000-508, Portugal

  • Universidad De Los Andes

    RECRUITING

    Las Condes, Chile

  • Universidade Estadual Paulista Julio De Mesquita Filho (UNESP) Hospital das Clinicas Faculdade de Medicina de Botucatu (HCFMB)

    RECRUITING

    São Paulo, Brazil

  • Universidade Federal de Goias

    RECRUITING

    Goiânia, Brazil

  • Universitair Ziekenhuis Antwerpen

    WITHDRAWN

    Edegem, Belgium

  • University Health Network (UHN) - Toronto General Hospital (TGH) - Toronto General Research Institute (TGRI)

    RECRUITING

    Toronto, Canada

  • University Hospital City Clinic Cancer Center

    RECRUITING

    Sofia, Bulgaria

  • University Of Miami School Of Medicine, Center For Liver Diseases

    RECRUITING

    Miami, Florida, 33136, United States

  • University Physicians and Surgeons Inc, dba Marshall Health

    RECRUITING

    Huntington, West Virginia, 25701, United States

  • University of Alberta - Faculty of Medicine & Dentistry - The Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR)

    RECRUITING

    Edmonton, Canada

  • University of California Davis Medical Center

    RECRUITING

    Sacramento, California, 95817, United States

  • University of California Los Angeles

    WITHDRAWN

    Los Angeles, California, 90404, United States

  • University of Chile Clinical Hospital (Hospital Clinico de la Universidad de Chile)

    RECRUITING

    Santiago, Chile

  • University of Colorado

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Kansas Medical Center (KUMC) - University of Kansas Liver Center - Hepatology Clinic

    NOT_YET_RECRUITING

    Kansas City, Kansas, 66160, United States

  • University of Malaya Medical Centre

    RECRUITING

    Kuala Lumpur, Malaysia

  • University of Michigan Health System

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • University of Pittsburgh

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • University of Texas Southwestern Medical Center at Dallas

    RECRUITING

    Dallas, Texas, 75390, United States

  • University of Virginia Medical Center

    RECRUITING

    Charlottesville, Virginia, 22903, United States

  • Univerzitna nemocnica L. Pasteura Kosice

    RECRUITING

    Košice, Slovakia

  • Uniwersyteckie Centrum Kliniczne im. Prof. K. Gibinskiego Slaskiego Uniwersytetu Medycznego

    RECRUITING

    Katowice, Poland

  • Velocity Clinical Research at Liver Institute Northwest

    RECRUITING

    Seattle, Washington, 98105, United States

  • Vilnius University Hospital Santaros Klinikos

    RECRUITING

    Vilnius, Lithuania

  • Virginia Commonwealth University Medical Center - West Hospital

    NOT_YET_RECRUITING

    Richmond, Virginia, 23298, United States

  • Waikato Hospital

    RECRUITING

    Hamilton, New Zealand

  • Westmead Hospital

    RECRUITING

    Westmead, Australia

  • Ziekenhuis Oost-Limburg

    WITHDRAWN

    Genk, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.